Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 91.42% | -11.89% | -42.37% | -40.66% | -28.48% |
| Total Other Revenue | -41.06% | -43.92% | -39.47% | -39.10% | -26.30% |
| Total Revenue | -13.67% | -37.53% | -40.08% | -39.43% | -26.76% |
| Cost of Revenue | -19.73% | -29.86% | -25.47% | -21.30% | -11.50% |
| Gross Profit | 19.04% | -59.17% | -77.82% | -82.21% | -62.06% |
| SG&A Expenses | 38.93% | 46.47% | 67.97% | 70.97% | 54.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 82.67% | 729.69% | -735.28% | -458.10% | 286.04% |
| Total Operating Expenses | 0.25% | -4.65% | -10.59% | -7.43% | 2.48% |
| Operating Income | -58.70% | -13,404.47% | -512.21% | -305.30% | -251.57% |
| Income Before Tax | -13.45% | 79.65% | 28.09% | -44.94% | -2,994.64% |
| Income Tax Expenses | 13.99% | -32.13% | 5.24% | 9.00% | 9.30% |
| Earnings from Continuing Operations | -13.45% | 79.62% | 28.07% | -44.90% | -2,928.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.45% | 79.62% | 28.07% | -44.90% | -2,928.45% |
| EBIT | -58.70% | -13,404.47% | -512.21% | -305.30% | -251.57% |
| EBITDA | -1,577.58% | -189.47% | -135.90% | -119.14% | -96.43% |
| EPS Basic | 66.25% | 112.26% | 83.19% | 62.06% | -2,036.01% |
| Normalized Basic EPS | 47.05% | 90.50% | 61.19% | 20.60% | -2,489.48% |
| EPS Diluted | 63.95% | 105.69% | 80.16% | 58.99% | -4,346.45% |
| Normalized Diluted EPS | 44.59% | 82.84% | 57.53% | 16.41% | -4,111.59% |
| Average Basic Shares Outstanding | 17.10% | 26.11% | 15.72% | 4.65% | -20.52% |
| Average Diluted Shares Outstanding | 24.87% | 38.20% | 14.70% | 4.18% | -20.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |